ARC’s Inaugural Masterclass a Success!
In early January, ARC hosted its first Masterclass, ‘Mastering the Art and Science of Amyloidosis.’ Over 75 healthcare providers were in attendance for the broad range of topics and comprehensive training, taught by leading amyloidosis experts.
ARC’s new healthcare provider educational Masterclass program was developed to better equip a broad range of clinicians to be able to identify the signs, symptoms and presentation of amyloidosis. This program provides a comprehensive training on diagnostic techniques, natural history of these diseases, and treatment options. The Masterclass was led by an internationally renowned faculty of amyloidosis experts and chaired by Vaishali Sanchorawala, MD, Director of the Boston University Amyloidosis Center. Speakers included Mathew Maurer, MD, a cardiologist from Columbia University Medical Center, Sami Khella, MD, a neurologist from Pennsylvania Presbyterian Medical Center, and Larry Anderson, MD, a hematologist at UT Southwestern Medical Center. The Masterclass also addressed the nuances of care; including prior authorizations, financial burden, barriers to treatment, and the importance of a multidisciplinary approach.
Over 75 clinicians from across the US were in attendance, ranging in specialties from cardiology, to neurology, nephrology, and hematology. The attendees arrived excited and eager to learn all things amyloid from the experts in the field and remained engaged during Q & A sessions, learning how they can better care for their amyloidosis patients.
The Masterclass included three hands-on breakout sessions, allowing the students to learn in smaller groups, ask more questions, and practice their skills. One of the most popular sessions was the fat pad aspiration, an important diagnostic technique, taught by Lisa Mendelson, NP of Boston University Medical Center. The attendees enjoyed the opportunity to practice the skill in this setting to then take back to their practice.
ARC would like to thank our expert panel of speakers for delivering such valuable content through engaging presentations, as well as a huge thank you to our pharmaceutical partners for providing educational grants to make the masterclass possible. Finally, thank you to the office of Continuing Medical Education at Boston University School of Medicine for partnering with us to make this an AMA PRA accredited course so that attendees could earn valuable CME credits.
Planning for future Masterclasses is already underway, and we look forward to sharing more details in the near future. Be sure to sign up for our newsletter to be kept up to date on our educational programs: https://arciorg.wpengine.com/newsletter/
- Categories
- Lastest Posts
- FDA Approves Attruby™ (acoramidis) for the Treatment of ATTR-CM: A New Option for Patients
- ARC Launches Clinical Fellowship Program to Advance Amyloidosis Care
- The More Things Change, the More They Stay the Same
- The Inflation Reduction Act: The Devil is in the Details for Patients with Rare Diseases